JP2006503806A5 - - Google Patents

Download PDF

Info

Publication number
JP2006503806A5
JP2006503806A5 JP2004508780A JP2004508780A JP2006503806A5 JP 2006503806 A5 JP2006503806 A5 JP 2006503806A5 JP 2004508780 A JP2004508780 A JP 2004508780A JP 2004508780 A JP2004508780 A JP 2004508780A JP 2006503806 A5 JP2006503806 A5 JP 2006503806A5
Authority
JP
Japan
Prior art keywords
pharmaceutical preparation
preparation according
active substance
ion exchanger
substance bound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004508780A
Other languages
English (en)
Japanese (ja)
Other versions
JP5350574B2 (ja
JP2006503806A (ja
Filing date
Publication date
Priority claimed from DE10224086A external-priority patent/DE10224086A1/de
Application filed filed Critical
Publication of JP2006503806A publication Critical patent/JP2006503806A/ja
Publication of JP2006503806A5 publication Critical patent/JP2006503806A5/ja
Application granted granted Critical
Publication of JP5350574B2 publication Critical patent/JP5350574B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004508780A 2002-05-31 2003-05-19 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 Expired - Lifetime JP5350574B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
DE10224086.8 2002-05-31
PCT/EP2003/005228 WO2003101422A2 (de) 2002-05-31 2003-05-19 Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010235021A Division JP2011012087A (ja) 2002-05-31 2010-10-20 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤

Publications (3)

Publication Number Publication Date
JP2006503806A JP2006503806A (ja) 2006-02-02
JP2006503806A5 true JP2006503806A5 (https=) 2006-07-06
JP5350574B2 JP5350574B2 (ja) 2013-11-27

Family

ID=29432468

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004508780A Expired - Lifetime JP5350574B2 (ja) 2002-05-31 2003-05-19 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤
JP2010235021A Withdrawn JP2011012087A (ja) 2002-05-31 2010-10-20 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010235021A Withdrawn JP2011012087A (ja) 2002-05-31 2010-10-20 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤

Country Status (27)

Country Link
US (1) US8545829B2 (https=)
EP (1) EP1513500B1 (https=)
JP (2) JP5350574B2 (https=)
KR (3) KR20050010015A (https=)
CN (1) CN1671361B (https=)
AR (2) AR039861A1 (https=)
AT (1) ATE421317T1 (https=)
AU (1) AU2003242545B2 (https=)
BR (2) BRPI0311511B1 (https=)
CA (1) CA2487648C (https=)
CR (1) CR7598A (https=)
DE (2) DE10224086A1 (https=)
DK (1) DK1513500T3 (https=)
ES (1) ES2319115T3 (https=)
HR (1) HRP20041219B1 (https=)
IL (2) IL165322A0 (https=)
MX (1) MXPA04011820A (https=)
MY (1) MY140953A (https=)
NO (1) NO333939B1 (https=)
PL (1) PL207269B1 (https=)
PT (1) PT1513500E (https=)
RU (1) RU2380091C2 (https=)
SI (1) SI1513500T1 (https=)
TW (1) TWI333422B (https=)
UA (1) UA84270C2 (https=)
WO (1) WO2003101422A2 (https=)
ZA (1) ZA200409616B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
US20080095842A1 (en) * 2004-12-06 2008-04-24 Antarkar Amit K Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
CA2661576A1 (en) 2006-09-26 2008-04-03 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
CA2719246A1 (en) * 2008-03-26 2009-10-01 Taro Pharmaceuticals North America, Inc. Stabilizing lipid compositions for oral pharmaceutical agents
PT2544532T (pt) 2010-03-12 2017-06-02 Monsanto Technology Llc Composições de gel agroquímicas
HRP20160901T1 (hr) * 2010-05-19 2016-10-07 Astellas Pharma Inc. Farmaceutski pripravak koji sadrži solifenacin
AU2012326513B2 (en) 2011-10-19 2016-03-17 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
JP7410050B2 (ja) 2018-04-25 2024-01-09 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング キノロンカルボン酸エステルの加水分解プロセス
KR102923598B1 (ko) * 2019-07-15 2026-02-09 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 포함하는 액상 시럽제제 및 이의 제조방법
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US614622A (en) * 1898-11-22 Machine for making billets
JPS60204713A (ja) 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
CA2117266C (en) * 1991-10-28 1998-01-06 John Robert Bunger Beverage thickener/emulsifier system
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
BR9707606B1 (pt) * 1996-02-23 2010-08-10 ácidos 8-ciano-1-ciclopropil-7-(2,8-diazabiciclo(4.3.0) nonan-8-il)-6-flúor-1,4-diidro-4-oxo-3-quinolinocarbo xìlicos, bem como medicamentos que os compreendem.
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE60040540D1 (de) * 1999-07-14 2008-11-27 Schering Plough Ltd Maskieren des geschmacks der oralen flüssigen chinolon-zubereitungen mit ionenaustauscherharzen
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Similar Documents

Publication Publication Date Title
JP2006503806A5 (https=)
CN101711752B (zh) 一种苯并异噁唑类衍生物的控释制剂及其制备方法
CA2487648A1 (en) Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
CN102083467B (zh) 固体分散体及其药物组合物、以及它们的制备方法
ES2427252T5 (es) Composición farmacéutica de fenofibrato que presenta una biodisponibilidad elevada y procedimiento de preparación
CN100562317C (zh) 含大量酸不稳定药物的颗粒
JPS62123112A (ja) 軟膏基剤
JP2009545560A5 (https=)
RU2009141538A (ru) Твердые лекарственные формы, содержащие тадалафил
CA2503361A1 (en) Controlled-release compositions
JP2006514967A5 (https=)
CN103006612B (zh) 一种赖诺普利迟释缓释片剂及其制备方法
EP2393486A1 (en) Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process
JP2011516544A5 (https=)
CN106794142A (zh) 核心组合物
WO2014111799A1 (es) Composición de difenidol de liberación prolongada
WO2011079764A1 (zh) 一种右旋佐匹克隆固体制剂及其制备方法
JP2010163428A (ja) 崩壊錠
JP2005500332A5 (https=)
JP2003518486A5 (https=)
JP4165224B2 (ja) 発泡性組成物
CN102697751A (zh) 一种畜禽专用恩诺沙星泡腾分散片及其制备方法
CN101890013A (zh) 用碱性试剂稳定的匹伐他汀钙组合物及其制备方法
JP4965096B2 (ja) 圧縮成型製剤
CN105412037B (zh) 一种罗红霉素缓控释制剂